Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3468-3474

  Duffey, Dianne C ^a   Chen, Zhong ^a   Dong, Gang ^a   Ondrey, Frank G ^a   Wolf, Jeffery S ^a   Brown, Keith ^b   Siebenlist, Ulrich ^b   Van Waes, Carter ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; GENES, REPORTER; HEAD AND NECK NEOPLASMS; HUMANS; I-KAPPA B PROTEINS; LAC OPERON; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; PHOSPHORYLATION; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033565217     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Chen, Z., Colon, I., Ortiz, N., Callister, M., Dong, G., Pegram, M. Y., Arosarena, O., Strome, S., Nicholson, J. C., and Van Waes, C. Effects of interleukin 1α, interleukin-1 receptor antagonist and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res., 58: 3668-3676, 1998.
2. Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., Kroog, G. S., Enamorado, I., McCullagh, L., Rudy, S., Yeh, N. T., Mousa, S., Quezado, M , Hersher, L., and Van Waes. C. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res., in press, 1999.
3. Woods, K. V., El-Nagger, A., Clayman, G. L., and Grimm, E. A. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res., 58: 3132-3141, 1998.
4. Mann, E., Spiro, J., Chen, L., and Kreutzer, D. Cytokine expression by head and neck squamous cell carcinoma. Am. J. Surg., 164: 567-573, 1992.
5. Cohen, R., Contrino, J., Spiro, J., Mann, E., Chen, L., and Kreutzer, D. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 121: 202-209, 1995.
6. Yamamura, M., Modlin, R., Ohmen, J., and Moy, R. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest., 91: 1005-1010, 1993.
7. Chopra, V., Dinh, T. V., and Hannigan, E. V. Circulating senim levels of cylokines and angiogenic factors in patients with cervical cancer. Cancer Invest., 16: 152-159, 1998.
8. Smith, D., Polverini, P., Kunkel, S., Orringer, M., Whyte, R., Burdick, M., Wilke, C., and Stricter, R. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med., 179: 1409-1415, 1994.
9. Chen, Z., Smith, C. W., Kiel, D., and Van Waes, C. Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin. Exp. Metastasis, 15: 527-537, 1997.
10. Dong, G., Loukinova, E., Smith, C. W., Chen, Z., and Van Waes, C. Genes differentially expressed with malignant transformation and metastatic tumor progress on of murine squamous cell carcinoma. J. Cell. Biochem. Suppl., 28/29: 90-100, 1997.
11. Smith, C. W., Chen, Z., Dong, G., Loukinova, E., and Van Waes, C. The host environment promotes the development of primary and melastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1α, IL-6, GM-CSF and KC. Clin. Exp. Metastasis, 16: 655-564, 1998.
12. Woodworth, C., McMullin, E., Iglesias, M., and Plowman, G. Interleukin 1 α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc. Natl. Acad. Sci. USA, 92: 2840-2844, 1995.
13. Young, M. R. I., Wright, M. A., Lozano, Y., Prechel, M. M., Benefield, J., Leonetti, J. P., Collins, S. L., and Petruzelli, G. J. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony stimulating factor and contained CD34+ natural suppressor cells. Int. J. Cancer, 74: 69-74, 1997.
14. Yoneda, T., Aufdemorte, T., Nishimura, R., Nishikawa, N., Sakuda, M., Alsina, M., Chavez, J., and Mundy, G. Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice. A novel experimental model of three concomitant paraneoplastic syndromes. J. Clin. Oncol., 9: 468-477, 1991.
15. Baeuerle, P. A. Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Curr. Biol., 8: R19-R22, 1998.
16. Bailly, S., Fay, M., Israel, N., and Gougerot-Pocidalo, M. A. The transcription factor AP-I binds to the human interleukin 1α promoter. Eur. Cytokine Netw., 7: 125-128, 1996.
17. Dendorfer, U., Oettgen P., and Libermann, T. A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol., 14: 4443-4454, 1994.
18. Mukaida, N., Okamoto, S., Ishikawa, Y., and Matsushima, K. Molecular mechanism of interleukin-8 gene expression. J. Leukocyte Biol., 56: 554-558, 1994.
19. Thomas, R. S., Tymms. M. J., McKinlay, L. H., Shannon, M. F., Seth, A., and Kola, I. ETS1, NFκB and AP1 synergistically transactivate the human GM-CSF promoter Oncogene, 14: 2845-2855, 1997.
20. Ondrey, F. G., Dong, G., Sunwoo, J., Chen, Z., Wolf, J. S., Crawl-Bancroft, C. V., Mukalda, N., and Van Waes, C. Constitutive activation of transcription factors NF-κB, AP-1 and NF-IL6 in human head and neck squamous cell carcinomas that express proinflammatory and proangiogenic cytokines. Mol. Carcinog., in press, 1999.
21. Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein T. L., Sherr D. H., and Sonenshein, G. E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J., 15: 4682-4690, 1996.
22. Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., and Dorken, B. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest., 100: 2961-2969, 1997.
23. Shattuck-Brandt, R. L., and Richmond, A. Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res., 57: 3032-3039, 1997.
24. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr., and Sledge, G. W., Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone independent growth. Mol. Cell. Biol., 17: 3629-3639, 1997.
25. Sovak, M. A., Bellas, R. E., Kim. D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., and Sonenshein, G. E. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest., 100: 2952-2960, 1997.
26. Cadoret, A., Bertrand, F., Baron-Delage, S., Levy, P., Courtois, G., Gespach, C., Capeau, J., and Cherqui, G. Down-regulation of NF-κB activity and NF-κB p65 subunit expression by ras and polyoma middle T oncogenes in human colonie Caco-2 cells. Oncogene, 14: 1589-1600, 1997.
27. Nehyba, J., Hrdlickova R., and Bose, H. R., Jr. Differences in κB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein. Oncogene, 14: 2881-2897, 1997.
28. Siebenlist, U. G., Franzoso, G., and Brown, K. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol., 10: 405-455, 1994.
29. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Washington DC), 267: 1485-1488, 1995.
30. Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., and Baeuerle, P. A. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J., 14: 2876-2883, 1995.
31. Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi, X., Lee, W. Y., and Ballard, D. W. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation Mol. Cell. Biol., 15: 2809-2818, 1995.
32. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev., 9: 2723-2735, 1995.
33. Beg, A. A., and Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Washington DC), 274: 782-784, 1996.
34. Wang, C-Y., Mayo, M. W., and Baldwin, A. S. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
35. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. Suppression of TNF-α-induced apoptosis by NF-κB Science (Washington DC), 274: 787-789, 1996.
36. Krause, C., Carey, T., Ott, R., Hurbis, C., McClatchey, K., and Regezi, J. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch. Otolaryngol., 107: 703-710, 1981.
37. Bradford, C. R., Kimmel, K. A., Van Dyke, D. L., Worsham, M. J., Tilley, B. J., Burk, D., del Rosario, F., Lutz, S., Tooley, R., Hayashida, D. J. S., and Carey, T. E. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody. Genes Chromosomes Cancer, 3: 272-282, 1991.
38. Van Waes, C., Mi Surh, D., Chen, Z., Kirby, M., Rhim, J. S., Brager, R., Sessions, R. B., Poore, J., Wolf, G. T., and Carey, T. E. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res., 55: 5434-5444, 1995.
39. Brown, K., Franzoso, G., Baldi, L., Carlson, L., Mills, L., Lin, Y. C., Gerstberger, S., and Siebenlist, U. The signal response of IκBa is regulated by transferable N- and C-terminal domains. Mol. Cell. Biol., 17: 3021-3027, 1997.
40. Sanes, J. R., Rubenstein, J. R., and Nicolas, J. F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J., 5: 3133-3142, 1986.
41. Harlow, E., and Lane, D. In: Antibodies. A Laboratory Manual, pp. 473-510 and 635-657. Cold Spring Harbor, NY: Cold Spring Harbor, 1988.
42. Garner, M. M., and Revzin, A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to the components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res., 9: 3047-3060, 1981.
43. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
44. Lee, K. A. W., Bindereif, A., and Green, M. R. A small scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech., 5: 22-31, 1988.
45. Kanno, T., Brown, K., and Siebenlist, U. Evidence in support of a role for human T cell leukemia virus type I Tax in activating NF-κB via stimulation of signaling pathways. J. Biol. Chem., 270: 11745-11748, 1995.
46. Kaltschmidt, C., Kaltschmidt, B., Henkel, T., Stockinger, H., and Baeuerle, P. A. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol. Chem. Hoppe-Seyler, 376: 9-16, 1995.
47. Wang, C-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science (Washington DC), 281: 1689-1683, 1998.
48. Wu, M. X., Ao, Z., Prasad, K. V. S., Wu, R., and Schlossman, S. F. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science (Washington DC), 281: 998-1001, 1998.
49. Zong, W. X., Edelstein, L. C., Chen, C., Bash, J., and Gelinas, C. The prosurvival BCl-2 homolog Bfl/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev., 13: 382-387, 1999.
50. Yuspa, S. H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. Cancer Res., 54: 1178-1189, 1994.
51. Li, J-J., Westergaard, C., Ghosh, P., and Cotburn, N. H. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57: 3569-3576, 1997.
52. Li, J-J., Rhim, J. S., Schlegel, R., Vousden, K. H., and Coburn, N. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene, 16: 2711-2721, 1998.
53. Grilli, M., Chiu, J. J-S., and Lenardo, M. L. NFκB and Rel participants in a multiform transcriptional regulatory system. Int. Rev. Cytol., 143: 1-62, 1993.
54. Sun, L., and Carpenter, G. Epidermal growth factor activation of NF-κB is mediated through IκBα degradation and intracellular free calcium. Oncogene, 16: 2095-2102, 1998.
55. Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., and Baldwin, A. S., Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (Washington DC), 278: 1812-1815, 1997.
56. Reuther, J. V., Reuther, G. W., Cortez, D., Pendergast, A. M., and Baldwin, A. S. A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev., 12: 968-981, 1998.